Clinical Trial Update: A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial evaluating Sacituzumab Tirumotecan in combination with Iparomlimab and Tuvonralimab for locally advanced cervical cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Sacituzumab Tirumotecan (Sacituzumab govitecan)
• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Zheng Min | Conditions: Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING